Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff
Status:
Recruiting
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
The investigators plan to carry out an experimental study on the preventive effect of
recombinant human interferon alpha nasal drops on the infection of 2019 new coronavirus in
medical staff.